Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Currency
EUR
Contacto rápido
Por favor envíeme más información sobre
Fmoc-L-Lys(Ggu-L-Glu(AA-AA))-OH
Nombre químico: Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH // Sinónimos: (23S,50S)-50-(((9H-fluoren-9-yl)methoxy)carbonylamino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oicacid, Semaglutide- Linker, Fmoc-Lys(Ggu-L-Glu(AA-AA)-OH
- Nº Artículo:FAA7640
- Nº CAS:1662688-20-1
- Fórmula:C64H101N5O16
- Storage temperature:-20°C
- Masa molecular:1196,51 g/mol
from 390,00 €
description
Dipeptide building block for SPPS synthesis of Semaglutide (brand name Ozempic). Semaglutide is a GLP-1 analogue and has been developed in 2012 by Novo Nordisk SA for the treatment of diabetes type 2 as a longer-acting alternative to liraglutide. It was found in 2017 that it also can be used for the treatment of obesity.
references
"Abstracts of the 48th EASD Annual Meeting of the European Association for the Study of Diabetes". Diabetologia 2012; 55(1): 1–538. DOI: 10.1007/s00125-012-2688-9.
¿Necesita más información sobre este producto?
ponerse en contacto
Folletos y volantes
¡Otros productos que también podrían interesarle!
